Zoetis Inc. Form SC 13D: Beneficial ownership report (active)
Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.
- 2016-07-08: Form SC 13D/A; Description SC 13D/A; Document d224141dsc13da.htm.
- 2016-05-10: Form SC 13D/A; Description SC 13D/A; Document d148635dsc13da.htm.
- 2016-04-22: Form SC 13D/A; Description SC 13D/A; Document d186445dsc13da.htm.
- 2015-04-13: Form SC 13D/A; Description SC 13D/A; Document d910514dsc13da.htm.
| Filed | Form | Period of report | Description | Document |
|---|---|---|---|---|
| 2016-07-08 | SC 13D/A | SC 13D/A | d224141dsc13da.htm | |
| 2016-05-10 | SC 13D/A | SC 13D/A | d148635dsc13da.htm | |
| 2016-04-22 | SC 13D/A | SC 13D/A | d186445dsc13da.htm | |
| 2015-04-13 | SC 13D/A | SC 13D/A | d910514dsc13da.htm | |
| 2015-02-04 | SC 13D/A | SC 13D/A | d865407dsc13da.htm | |
| 2015-02-04 | SC 13D/A | SC 13D/A | d865041dsc13da.htm | |
| 2014-12-05 | SC 13D/A | SC 13D/A | d835783dsc13da.htm | |
| 2014-11-12 | SC 13D | SC 13D | d819206dsc13d.htm | |
| 2014-11-12 | SC 13D | SC 13D | d820330dsc13d.htm |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |